U.S.-China fentanyl dispute reflects systemic trade and drug policy tensions
Original framing: “US and China clash over fentanyl and tariffs at global drugs meeting - Reuters” — Reuters (via Google News)
The dispute’s absurdity lies in how both nations weaponize drug policy for domestic political gain while ignoring the root causes of the crisis, revealing a shared hypocrisy masked by solemn diplomacy. A trickster lens exposes how the 'serious' conflict is, in fact, a farce of performative sovereignty and manufactured outrage.
The U.S.-China fentanyl dispute is a microcosm of broader systemic tensions in global governance, where trade policy, drug enforcement, and geopolitical strategy intersect.
Indigenous and community-based models of drug policy offer alternative frameworks that emphasize healing and prevention over punishment. Historical precedents, such as the Opium Wars, reveal how drug policy has long been used as a tool of economic and political control. A systemic solution requires integrating scientific research, cross-cultural perspectives, and marginalized voices into policy-making. This includes reforming trade agreements to support ethical manufacturing, investing in community-led rehabilitation, and leveraging AI for more transparent and adaptive governance.